×

Sustained release thyroactive composition

  • US 5,324,522 A
  • Filed: 12/28/1992
  • Issued: 06/28/1994
  • Est. Priority Date: 12/30/1991
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical composition for thyroid hormone replacement therapy comprising thyroxine and a controlled release form of 3,5,3'"'"'-triiodothyronine, said preparation containing from 1 to 50 parts of thyroxine to one part of 3,5,3'"'"'-triiodothyronine or pharmaceutically acceptable salts thereof.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×